Neonatal bleeding and decreased plasma fibrinogen levels in mice modeled after the dysfibrinogen Vlissingen/Frankfurt IV.
Hogan
K A
KA
Merenbloom
B K
BK
Kim
H S
HS
Lord
S T
ST
D000818:Animals; D002118:Calcium / Q000378:metabolism; D017931:DNA Primers; D004195:Disease Models, Animal; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D005340:Fibrinogen / Q000096:biosynthesis* / Q000378:metabolism; D015241:Fibrinogens, Abnormal / Q000737:chemistry / Q000235:genetics*; D005341:Fibrinolysin / Q000378:metabolism; D005822:Genetic Vectors; D005838:Genotype; D006579:Heterozygote; D006720:Homozygote; D015151:Immunoblotting; D008099:Liver / Q000378:metabolism; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D009154:Mutation; D010641:Phenotype; D012333:RNA, Messenger / Q000378:metabolism; D020133:Reverse Transcriptase Polymerase Chain Reaction; D013997:Time Factors
D017931:DNA Primers; D015241:Fibrinogens, Abnormal; D012333:RNA, Messenger; D005340:Fibrinogen; D005341:Fibrinolysin; D002118:Calcium